Data / Form D filings / SLAM BioTherapeutics, Inc.
SLAM BioTherapeutics, Inc.: Form D filings
SLAM BioTherapeutics, Inc., a biotechnology company in Westlake Village, CA, filed 3 Form D notices with the SEC between 2023 and 2025. The latest, on December 29, 2025, reports $1 million sold of a $4 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2945 TOWNSGATE RD., SUITE 200, Westlake Village, CA, 91361
- Phone
- (617) 513-4934
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1983523
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | New notice | $4,000,000 | $1,000,000 | $3,000,000 | 1 | Dec 19, 2025 | sec.gov |
| Mar 3, 2025 | New notice | $10,000,000 | $500,000 | $9,500,000 | 1 | Feb 20, 2025 | sec.gov |
| Nov 13, 2023 | New notice | $20,000,000 | $7,705,000 | $12,295,000 | 38 | Nov 3, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard Heinick | Executive Officer, Director | |
| Ted Schwartz | Director | |
| Steve Pazol | Director | |
| Mark Hagler | Director | |
| David Vennettilli | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Dec 29, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SLAM BioTherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.